The “One-to-Many” Survival Analysis to Evaluate a New Treatment in Comparison With Therapeutic Alternatives Based on Reconstructed Patient Data: Enfortumab Vedotin Versus Standard of Care in Advanced or Metastatic Urothelial Carcinoma-Reference-Cited by-同舟云学术

The “One-to-Many” Survival Analysis to Evaluate a New Treatment in Comparison With Therapeutic Alternatives Based on Reconstructed Patient Data: Enfortumab Vedotin Versus Standard of Care in Advanced or Metastatic Urothelial Carcinoma

Published:2022-08-25 Issue: Volume: Page:
ISSN:2168-8184
Container-title:Cureus
language:en
Short-container-title:

Author:

Messori Andrea,Rivano Melania,Cancanelli Luca,Damuzzo Vera,Ossato Andrea,Chiumente Marco,Mengato Daniele

Publisher

Cureus, Inc.

Subject

Aerospace Engineering

Reference18 articles.

1. IPDfromKM: reconstruct individual patient data from published Kaplan-Meier survival curves;Liu N;BMC Med Res Methodol,2021

2. Synthetizing published evidence on survival by reconstruction of patient-level data and generation of a multi-trial Kaplan-Meier curve;Messori A;Cureus,2021

3. Efficacy of immune checkpoint inhibitors in patients with mismatch repair-deficient or microsatellite instability-high metastatic colorectal cancer: analysis of three phase-II trials;Cancanelli L;Cureus,2021

4. A preliminary estimate of survival gain and cost-effectiveness of CAR-T in adult patients with acute lymphoblastic leukemia;Messori A;Leuk Lymphoma,2022

5. The degree of programmed death-ligand 1 (PD-L1) positivity as a determinant of outcomes in metastatic triple-negative breast cancer treated with first-line immune checkpoint inhibitors;Di Spazio L;Cureus,2022

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tislelizumab plus chemotherapy vs. pembrolizumab plus chemotherapy for the first-line treatment of advanced non-small cell lung cancer: systematic review and indirect comparison of randomized trials;Chinese Clinical Oncology;2023-10

2. Progression-Free and Overall Survival of First-Line Treatments for Advanced Renal Cell Carcinoma: Indirect Comparison of Six Combination Regimens;Cancers;2023-03-29

3. Application of the IPDfromKM-Shiny Method to Compare the Efficacy of Novel Treatments Aimed at the Same Disease Condition: A Report of 14 Analyses;Cancers;2023-03-07